pTH (13-34) (human)
pTH (13-34) (human) structure
|
Common Name | pTH (13-34) (human) | ||
|---|---|---|---|---|
| CAS Number | 81306-64-1 | Molecular Weight | 2808.22 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C125H199N39O33S | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
|
Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues.
J. Biol. Chem. 250 , 3199-3203, (1975) Two synthetic analogues of bovine parathyroid hormone (PTH) with NH2-terminal modifications, PTH-(3-34) and [desamino-Ala-1]PTH-(1-34), were found to lack agonist activity but to demonstrate antagonist properties when tested in the rat renal cortical adenylyl... |
|
|
Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.
Clin. J. Am. Soc. Nephrol. 1 , 525-531, (2006) Measurement of bioactive parathyroid hormone (PTH) is essential for optimal management of bone abnormalities in dialysis patients. This can be accomplished by PTH measurements using third-generation PTH assays, which detect more or less of the first six amino... |
|
|
Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Clin. Lab. 51 , 21-29, (2005) Most of what we know on PTH bioactivity has been associated with the first 34 amino acids of the PTH structure acting on the type I PTH/PTHrP receptor, leaving little place to the carboxyl-terminal structure. This reality has dictated the evolution of the PTH... |